Literature DB >> 16189139

Lengthy antimalarial activity of atovaquone in human plasma following atovaquone-proguanil administration.

M D Edstein, B M Kotecka, K L Anderson, D J Pombo, D E Kyle, K H Rieckmann, M F Good.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16189139      PMCID： PMC1251540          DOI： 10.1128/AAC.49.10.4421-4422.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  11 in total

1.  Pharmacokinetics of proguanil in malaria patients treated with proguanil plus atovaquone.

Authors:  M D Edstein; S Looareesuwan; C Viravan; D E Kyle
Journal:  Southeast Asian J Trop Med Public Health       Date:  1996-06       Impact factor: 0.267

2.  The pharmacokinetics and activation of proguanil in man: consequences of variability in drug metabolism.

Authors:  N A Helsby; S A Ward; G Edwards; R E Howells; A M Breckenridge
Journal:  Br J Clin Pharmacol       Date:  1990-10       Impact factor: 4.335

3.  Absence of an interaction between artesunate and atovaquone--proguanil.

Authors:  M van Vugt; M D Edstein; S Proux; K Lay; M Ooh; S Looareesuwan; N J White; F Nosten
Journal:  Eur J Clin Pharmacol       Date:  1999-08       Impact factor: 2.953

4.  Population pharmacokinetics of atovaquone in patients with acute malaria caused by Plasmodium falciparum.

Authors:  Z Hussein; J Eaves; D B Hutchinson; C J Canfield
Journal:  Clin Pharmacol Ther       Date:  1997-05       Impact factor: 6.875

5.  Population pharmacokinetics of proguanil in patients with acute P. falciparum malaria after combined therapy with atovaquone.

Authors:  Z Hussein; C J Eaves; D B Hutchinson; C J Canfield
Journal:  Br J Clin Pharmacol       Date:  1996-11       Impact factor: 4.335

6.  Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum.

Authors:  David J Pombo; Gregor Lawrence; Chakrit Hirunpetcharat; Christine Rzepczyk; Michelle Bryden; Nicole Cloonan; Karen Anderson; Yuvadee Mahakunkijcharoen; Laura B Martin; Danny Wilson; Salenna Elliott; Suzanne Elliott; Damon P Eisen; J Brice Weinberg; Allan Saul; Michael F Good
Journal:  Lancet       Date:  2002-08-24       Impact factor: 79.321

7.  Chloroquine bioassay using malaria microcultures.

Authors:  B M Kotecka; K H Rieckmann
Journal:  Am J Trop Med Hyg       Date:  1993-10       Impact factor: 2.345

8.  Examination of some factors responsible for a food-induced increase in absorption of atovaquone.

Authors:  P E Rolan; A J Mercer; B C Weatherley; T Holdich; H Meire; R W Peck; G Ridout; J Posner
Journal:  Br J Clin Pharmacol       Date:  1994-01       Impact factor: 4.335

9.  Persistence of atovaquone in human sera following treatment: inhibition of Plasmodium falciparum development in vivo and in vitro.

Authors:  Geoff A Butcher; Robert E Sinden
Journal:  Am J Trop Med Hyg       Date:  2003-01       Impact factor: 2.345

10.  Efficacy and pharmacokinetics of atovaquone and proguanil in children with multidrug-resistant Plasmodium falciparum malaria.

Authors:  A Sabchareon; P Attanath; P Phanuaksook; P Chanthavanich; Y Poonpanich; D Mookmanee; T Chongsuphajaisiddhi; B M Sadler; Z Hussein; C J Canfield; D B Hutchinson
Journal:  Trans R Soc Trop Med Hyg       Date:  1998 Mar-Apr       Impact factor: 2.184
View more
  25 in total

Review 1.  Controlled human blood stage malaria infection: current status and potential applications.

Authors:  Christopher J A Duncan; Simon J Draper
Journal:  Am J Trop Med Hyg       Date:  2012-04       Impact factor: 2.345

Review 2.  Approaches to malaria vaccine development using the retrospectroscope.

Authors:  Vanessa Sardá; David C Kaslow; Kim C Williamson
Journal:  Infect Immun       Date:  2009-05-18       Impact factor: 3.441

3.  Statins as potential antimalarial drugs: low relative potency and lack of synergy with conventional antimalarial drugs.

Authors:  Rina P M Wong; Timothy M E Davis
Journal:  Antimicrob Agents Chemother       Date:  2009-03-02       Impact factor: 5.191

4.  Atovaquone and ELQ-300 Combination Therapy as a Novel Dual-Site Cytochrome bc1 Inhibition Strategy for Malaria.

Authors:  Allison M Stickles; Martin J Smilkstein; Joanne M Morrisey; Yuexin Li; Isaac P Forquer; Jane X Kelly; Sovitj Pou; Rolf W Winter; Aaron Nilsen; Akhil B Vaidya; Michael K Riscoe
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

5.  In vitro antimalarial activity and drug interactions of fenofibric acid.

Authors:  Rina P M Wong; Timothy M E Davis
Journal:  Antimicrob Agents Chemother       Date:  2012-03-19       Impact factor: 5.191

Review 6.  Advances and challenges in malaria vaccine development.

Authors:  Peter D Crompton; Susan K Pierce; Louis H Miller
Journal:  J Clin Invest       Date:  2010-12-01       Impact factor: 14.808

Review 7.  Chemical Attenuation in the Development of a Whole-Organism Malaria Vaccine.

Authors:  Amber I Raja; Danielle I Stanisic; Michael F Good
Journal:  Infect Immun       Date:  2017-06-20       Impact factor: 3.441

8.  Protection against malaria after immunization by chloroquine prophylaxis and sporozoites is mediated by preerythrocytic immunity.

Authors:  Else M Bijker; Guido J H Bastiaens; Anne C Teirlinck; Geert-Jan van Gemert; Wouter Graumans; Marga van de Vegte-Bolmer; Rianne Siebelink-Stoter; Theo Arens; Karina Teelen; Wiebke Nahrendorf; Edmond J Remarque; Will Roeffen; Annemieke Jansens; Dunja Zimmerman; Martijn Vos; Ben C L van Schaijk; Jorien Wiersma; André J A M van der Ven; Quirijn de Mast; Lisette van Lieshout; Jaco J Verweij; Cornelus C Hermsen; Anja Scholzen; Robert W Sauerwein
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-18       Impact factor: 11.205

9.  Cross-species malaria immunity induced by chemically attenuated parasites.

Authors:  Michael F Good; Jennifer M Reiman; I Bibiana Rodriguez; Koichi Ito; Stephanie K Yanow; Ibrahim M El-Deeb; Michael R Batzloff; Danielle I Stanisic; Christian Engwerda; Terry Spithill; Stephen L Hoffman; Moses Lee; Virginia McPhun
Journal:  J Clin Invest       Date:  2013-07-01       Impact factor: 14.808

10.  Human T cell recognition of the blood stage antigen Plasmodium hypoxanthine guanine xanthine phosphoribosyl transferase (HGXPRT) in acute malaria.

Authors:  Tonia Woodberry; Alberto Pinzon-Charry; Kim A Piera; Yawalak Panpisutchai; Christian R Engwerda; Denise L Doolan; Ervi Salwati; Enny Kenangalem; Emiliana Tjitra; Ric N Price; Michael F Good; Nicholas M Anstey
Journal:  Malar J       Date:  2009-06-07       Impact factor: 2.979
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.